News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,937 Results
Type
Article (27)
Press Release (2910)
Section
Business (1334)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2104)
Policy (116)
Tag
Academia (3)
Alliances (42)
Alzheimer's disease (27)
Approvals (103)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (296)
Breast cancer (4)
Cancer (42)
Career advice (1)
Clinical research (615)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (51)
Diabetes (1)
Diagnostics (19)
Earnings (1351)
Events (319)
FDA (114)
Frontotemporal dementia (1)
Funding (2)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (8)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
Job creations (1)
Job search strategy (1)
Kidney cancer (1)
Layoffs (2)
Legal (1)
Lung cancer (18)
Lymphoma (6)
Manufacturing (1)
MASH (2)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (4)
Multiple sclerosis (2)
NASH (1)
Neuroscience (33)
NextGen: Class of 2025 (9)
Non-profit (4)
Northern California (22)
Obesity (1)
Parkinson's disease (1)
People (8)
Phase I (94)
Phase II (187)
Phase III (361)
Pipeline (25)
Postmarket research (27)
Preclinical (11)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (3)
Regulatory (132)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Schizophrenia (2)
Southern California (8)
Startups (3)
United States (183)
Vaccines (2)
Date
Today (3)
Last 7 days (9)
Last 30 days (20)
Last 365 days (418)
2025 (20)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (327)
Australia (12)
California (32)
Canada (11)
China (6)
Delaware (11)
Europe (580)
Florida (5)
Georgia (2)
Illinois (3)
Indiana (14)
Japan (7)
Maryland (6)
Massachusetts (27)
Minnesota (1)
New Jersey (33)
New York (21)
North Carolina (6)
Northern California (22)
Ohio (2)
Pennsylvania (14)
South America (5)
Southern California (8)
Texas (4)
Utah (4)
Washington State (2)
2,937 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
January 27, 2025
·
19 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
January 30, 2025
·
23 min read
Press Releases
Enterome to Host Webinar on New Clinical Data From the Ongoing Phase 1/2 ‘SIDNEY’ Trial of Lead Programme, EO2463
November 13, 2024
·
4 min read
Press Releases
Hidden Fat Predicts Alzheimer’s 20 Years Ahead of Symptoms
December 2, 2024
·
5 min read
Press Releases
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
December 23, 2024
·
19 min read
Press Releases
Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
January 13, 2025
·
12 min read
Press Releases
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast
January 31, 2025
·
6 min read
Press Releases
Takeda’s FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)
January 20, 2025
·
6 min read
1 of 294
Next